We are live on ! Find out more
PRC

Platte River Capital Portfolio holdings

AUM $108M
1-Year Est. Return 0.26%
This Fund
S&P 500
This Quarter Est. Return
+9.82%
1 Year Est. Return
-0.26%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$780M
AUM Growth
-$30.9M
Cap. Flow
-$95.7M
Cap. Flow %
-12.27%
Top 10 Hldgs %
21.67%
Holding
243
New
41
Increased
37
Reduced
116
Closed
34

Top Sells

Rank Stock Value
1
BAX icon
Baxter International
BAX
+$6.51M
2
GILD icon
Gilead Sciences
GILD
+$6.38M
3
ISRG icon
Intuitive Surgical
ISRG
+$6.28M
4
EXC icon
Exelon
EXC
+$5.8M
5
MDT icon
Medtronic
MDT
+$5.27M

Sector Composition

Rank Sector Weight
1 Healthcare 19.97%
2 Technology 16.47%
3 Energy 12.98%
4 Financials 11.71%
5 Consumer Staples 7.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
K
26
DELISTED
Kellanova
K
$7.44M 0.95%
129,793
-32,706
-20% -$1.88M
CCL icon
27
Carnival Corporation Ltd
CCL
$36.1B
$7.38M 0.95%
183,710
-27,380
-13% -$967K
PCG icon
28
PG&E
PCG
$47.8B
$7.12M 0.91%
176,650
-23,430
-12% -$960K
APA icon
29
APA Corp
APA
$12.8B
$7.09M 0.91%
82,520
+2,020
+3% +$180K
WBA
30
DELISTED
Walgreens Boots Alliance
WBA
$7.05M 0.9%
122,772
-9,475
-7% -$551K
LVLT
31
DELISTED
Level 3 Communications Inc
LVLT
$7.03M 0.9%
212,020
-29,000
-12% -$855K
ENDP
32
DELISTED
Endo International plc
ENDP
$7.02M 0.9%
104,020
-8,890
-8% -$507K
YHOO
33
DELISTED
Yahoo Inc
YHOO
$6.95M 0.89%
171,785
-16,715
-9% -$600K
ABBV icon
34
AbbVie
ABBV
$458B
$6.71M 0.86%
127,020
+30,600
+32% +$1.5M
ETN icon
35
Eaton
ETN
$157B
$6.69M 0.86%
87,890
-12,400
-12% -$882K
ABT icon
36
Abbott
ABT
$180B
$6.62M 0.85%
172,750
-10,130
-6% -$373K
EMC
37
DELISTED
EMC CORPORATION
EMC
$6.56M 0.84%
260,856
-23,455
-8% -$568K
JPM icon
38
JPMorgan Chase
JPM
$939B
$6.49M 0.83%
110,940
-18,030
-14% -$988K
BHI
39
DELISTED
Baker Hughes
BHI
$6.27M 0.8%
113,510
-150
-0.1% -$8.22K
AMAT icon
40
Applied Materials
AMAT
$426B
$6.24M 0.8%
352,720
+58,670
+20% +$1.02M
INTC icon
41
Intel
INTC
$466B
$6.23M 0.8%
239,860
-68,630
-22% -$1.66M
CME icon
42
CME Group
CME
$92.2B
$6.06M 0.78%
77,260
+24,540
+47% +$1.92M
QCOM icon
43
Qualcomm
QCOM
$176B
$6.03M 0.77%
81,232
-6,460
-7% -$456K
WFT
44
DELISTED
Weatherford International plc
WFT
$6.01M 0.77%
387,706
-58,280
-13% -$926K
DBD
45
DELISTED
Diebold Nixdorf Incorporated
DBD
$5.76M 0.74%
174,580
+8,500
+5% +$265K
SYK icon
46
Stryker
SYK
$127B
$5.51M 0.71%
73,360
-35,180
-32% -$2.57M
SLB icon
47
SLB Ltd
SLB
$77.8B
$5.43M 0.7%
60,306
-6,480
-10% -$585K
APC
48
DELISTED
Anadarko Petroleum
APC
$5.41M 0.69%
68,178
+65
+0.1% +$5.83K
TEVA icon
49
Teva Pharmaceuticals
TEVA
$35.9B
$5.38M 0.69%
134,125
+15,040
+13% +$592K
SLM icon
50
SLM Corp
SLM
$4.57B
$5.27M 0.68%
+561,503
New +$5.16M

Similar funds

Platte River Capital's Q4 2013 Portfolio in Review

As of Q4 2013, Platte River Capital held 243 positions worth $780M, down 3.8% from $811M the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Platte River Capital withdrew a net $95.7M in Q4 2013, closing 34 positions and reducing 116 holdings. Its most notable exit was Baxter International, an estimated $6.51M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 22% a quarter earlier, followed by Technology and Energy.

Against the trend, Platte River Capital opened a new position in SLM Corp worth $5.27M.

  • Platte River Capital's largest Q4 2013 buy was SLM Corp: 561,503 shares worth $5.27M.
  • Platte River Capital added most to Caterpillar in Q4 2013, an estimated $2.54M increase.
  • Platte River Capital's biggest Q4 2013 reduction was Gilead Sciences, cutting an estimated $6.38M.
  • Platte River Capital fully exited Baxter International in Q4 2013, selling an estimated $6.51M.
  • Platte River Capital's ten largest holdings make up 22% of its $780M portfolio in Q4 2013.
  • Platte River Capital opened 41 new positions and closed 34 in Q4 2013.
  • Platte River Capital's portfolio value fell 3.8% quarter-over-quarter to $780M.

Based on Platte River Capital's 13F filing for Q4 2013, filed 4 Feb 2014.